245 related articles for article (PubMed ID: 20681793)
41. Effects on human transcriptome of mutated BRCA1 BRCT domain: a microarray study.
Iofrida C; Melissari E; Mariotti V; Guglielmi C; Guidugli L; Caligo MA; Pellegrini S
BMC Cancer; 2012 May; 12():207. PubMed ID: 22646717
[TBL] [Abstract][Full Text] [Related]
42. Molecular mechanism of the recruitment of NBS1/hMRE11/hRAD50 complex to DNA double-strand breaks: NBS1 binds to gamma-H2AX through FHA/BRCT domain.
Kobayashi J
J Radiat Res; 2004 Dec; 45(4):473-8. PubMed ID: 15635255
[TBL] [Abstract][Full Text] [Related]
43. Structure of a second BRCT domain identified in the nijmegen breakage syndrome protein Nbs1 and its function in an MDC1-dependent localization of Nbs1 to DNA damage sites.
Xu C; Wu L; Cui G; Botuyan MV; Chen J; Mer G
J Mol Biol; 2008 Aug; 381(2):361-72. PubMed ID: 18582474
[TBL] [Abstract][Full Text] [Related]
44. CCDC98 is a BRCA1-BRCT domain-binding protein involved in the DNA damage response.
Kim H; Huang J; Chen J
Nat Struct Mol Biol; 2007 Aug; 14(8):710-5. PubMed ID: 17643122
[TBL] [Abstract][Full Text] [Related]
45. BRCA1-directed, enhanced and aberrant homologous recombination: mechanism and potential treatment strategies.
Dever SM; White ER; Hartman MC; Valerie K
Cell Cycle; 2012 Feb; 11(4):687-94. PubMed ID: 22306997
[TBL] [Abstract][Full Text] [Related]
46. E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks.
Reid LJ; Shakya R; Modi AP; Lokshin M; Cheng JT; Jasin M; Baer R; Ludwig T
Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20876-81. PubMed ID: 19088202
[TBL] [Abstract][Full Text] [Related]
47. Identification of a RING protein that can interact in vivo with the BRCA1 gene product.
Wu LC; Wang ZW; Tsan JT; Spillman MA; Phung A; Xu XL; Yang MC; Hwang LY; Bowcock AM; Baer R
Nat Genet; 1996 Dec; 14(4):430-40. PubMed ID: 8944023
[TBL] [Abstract][Full Text] [Related]
48. SIRT2 promotes BRCA1-BARD1 heterodimerization through deacetylation.
Minten EV; Kapoor-Vazirani P; Li C; Zhang H; Balakrishnan K; Yu DS
Cell Rep; 2021 Mar; 34(13):108921. PubMed ID: 33789098
[TBL] [Abstract][Full Text] [Related]
49. PI 3 kinase related kinases-independent proteolysis of BRCA1 regulates Rad51 recruitment during genotoxic stress in human cells.
Hammond-Martel I; Pak H; Yu H; Rouget R; Horwitz AA; Parvin JD; Drobetsky EA; Affar el B
PLoS One; 2010 Nov; 5(11):e14027. PubMed ID: 21103343
[TBL] [Abstract][Full Text] [Related]
50. BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites.
Hu Z; Mi S; Zhao T; Peng C; Peng Y; Chen L; Zhu W; Yao Y; Song Q; Li X; Li X; Jia C; Pei H
EMBO J; 2020 Jun; 39(12):e104133. PubMed ID: 32347575
[TBL] [Abstract][Full Text] [Related]
51. Thermal denaturation of the BRCT tandem repeat region of human tumour suppressor gene product BRCA1.
Pyrpassopoulos S; Ladopoulou A; Vlassi M; Papanikolau Y; Vorgias CE; Yannoukakos D; Nounesis G
Biophys Chem; 2005 Apr; 114(1):1-12. PubMed ID: 15792855
[TBL] [Abstract][Full Text] [Related]
52. The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection.
Billing D; Horiguchi M; Wu-Baer F; Taglialatela A; Leuzzi G; Nanez SA; Jiang W; Zha S; Szabolcs M; Lin CS; Ciccia A; Baer R
Mol Cell; 2018 Oct; 72(1):127-139.e8. PubMed ID: 30244837
[TBL] [Abstract][Full Text] [Related]
53. The BRCA1 C-terminal domain: structure and function.
Huyton T; Bates PA; Zhang X; Sternberg MJ; Freemont PS
Mutat Res; 2000 Aug; 460(3-4):319-32. PubMed ID: 10946236
[TBL] [Abstract][Full Text] [Related]
54. Crystal structure of the BARD1 BRCT domains.
Birrane G; Varma AK; Soni A; Ladias JA
Biochemistry; 2007 Jul; 46(26):7706-12. PubMed ID: 17550235
[TBL] [Abstract][Full Text] [Related]
55. Insights into the molecular basis of human hereditary breast cancer from studies of the BRCA1 BRCT domain.
Glover JN
Fam Cancer; 2006; 5(1):89-93. PubMed ID: 16528612
[TBL] [Abstract][Full Text] [Related]
56. Cancer-related mutations in BRCA1-BRCT cause long-range structural changes in protein-protein binding sites: a molecular dynamics study.
Gough CA; Gojobori T; Imanishi T
Proteins; 2007 Jan; 66(1):69-86. PubMed ID: 17063491
[TBL] [Abstract][Full Text] [Related]
57. Cancer predisposing mutations in BRCT domains.
di Masi A; Gullotta F; Cappadonna V; Leboffe L; Ascenzi P
IUBMB Life; 2011 Jul; 63(7):503-12. PubMed ID: 21698754
[TBL] [Abstract][Full Text] [Related]
58.
Drikos I; Boutou E; Kastritis PL; Vorgias CE
Anticancer Res; 2021 Jun; 41(6):2953-2962. PubMed ID: 34083286
[TBL] [Abstract][Full Text] [Related]
59. MDC1 is a mediator of the mammalian DNA damage checkpoint.
Stewart GS; Wang B; Bignell CR; Taylor AM; Elledge SJ
Nature; 2003 Feb; 421(6926):961-6. PubMed ID: 12607005
[TBL] [Abstract][Full Text] [Related]
60. Substitution of aspartic acid with glutamic acid at position 67 of the BRCA1 RING domain retains ubiquitin ligase activity and zinc(II) binding with a reduced transition temperature.
Atipairin A; Canyuk B; Ratanaphan A
J Biol Inorg Chem; 2011 Feb; 16(2):217-26. PubMed ID: 20967475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
